APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Infusion Center

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

An overpressure event refers to any condition which would cause pressure in a vessel or system to increase beyond the specified design pressure or maximum allowable working pressure (MAWP).

The primary purpose of a pressure Relief Valve is protection of life and property by venting fluid from an overpressurized vessel.

The spring-loaded relief valve is a conventional pressure relief valve that is commonly used in liquid service valves. The valve opens proportionally as the pressure increases to overcome the spring pressure.

Selected research

Market Analysis & Forecast

Global Ambulatory Infusion Center Market Analysis and Forecast 2026-2032

Report ID 173896630231 December 2025198 pages

Choose your research edition.

Industry ResearchAmbulatory Infusion Center Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Infusion Center Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ambulatory Infusion Center Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Infusion Center Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambulatory Infusion Center Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Ambulatory Infusion is the administration of chemotherapy, medications or fluids into the bloodstream through a needle or catheter. Ambulatory Infusion Center helps patients who require infusions of chemotherapy, antibiotics, blood products or other therapies on an outpatient basis.

An overpressure event refers to any condition which would cause pressure in a vessel or system to increase beyond the specified design pressure or maximum allowable working pressure (MAWP).

The primary purpose of a pressure Relief Valve is protection of life and property by venting fluid from an overpressurized vessel.

Read the full market overview

The spring-loaded relief valve is a conventional pressure relief valve that is commonly used in liquid service valves. The valve opens proportionally as the pressure increases to overcome the spring pressure.

Geographically, the global Ambulatory Infusion Center market has been segmented into Americas, Europe, Asia-Pacific and Middle East & Africa. Americas is the dominant market in the global Ambulatory Infusion Center market in terms of value.

The leading players mainly are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, UK HealthCare, CHI Health, Accredo Health, PharMerica, Cleveland Clinic, etc. The market is very fragmented because of numerous hospital outpatient infusion services and clinic services.

Report Includes

This report presents an overview of global market for Ambulatory Infusion Center, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ambulatory Infusion Center, also provides the revenue of main regions and countries. Of the upcoming market potential for Ambulatory Infusion Center, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ambulatory Infusion Center revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ambulatory Infusion Center market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ambulatory Infusion Center revenue, projected growth trends, production technology, application and end-user industry.

Ambulatory Infusion Center Segment by Company

Option Care Health

Coram CVS

UnitedHealth Group

HCA Healthcare

McLaren

UK HealthCare

CHI Health

Accredo Health

PharMerica

Cleveland Clinic

Ambulatory Infusion Center Segment by Type

Hospital

Clinic

Home Health Agencies

Ambulatory Infusion Center Segment by Application

Cancer

Chronic Disease

Others

Ambulatory Infusion Center Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Infusion Center market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Infusion Center and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Infusion Center.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ambulatory Infusion Center in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ambulatory Infusion Center company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ambulatory Infusion Center revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ambulatory Infusion Center Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hospital Major Player Table 3. Clinic Major Player Table 4. Home Health Agencies Major Player Table 5. Global Ambulatory Infusion Center Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Major Player Table 7. Chronic Disease Major Player Table 8. Others Major Player Table 9. Ambulatory Infusion Center Industry Trends Table 10. Ambulatory Infusion Center Industry Drivers Table 11. Ambulatory Infusion Center Industry Opportunities and Challenges Table 12. Ambulatory Infusion Center Industry Restraints Table 13. Global Ambulatory Infusion Center Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Ambulatory Infusion Center Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Ambulatory Infusion Center Market Share by Region (2021-2026) Table 16. Global Ambulatory Infusion Center Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Ambulatory Infusion Center Market Share by Region (2027-2032) Table 18. Global Ambulatory Infusion Center Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Ambulatory Infusion Center Revenue Market Share by Players (2021-2026) Table 20. Global Ambulatory Infusion Center Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Ambulatory Infusion Center Key Players Headquarters & Area Served Table 22. Global Ambulatory Infusion Center Players, Product Type & Application Table 23. Global Ambulatory Infusion Center Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Ambulatory Infusion Center by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Ambulatory Infusion Center Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Ambulatory Infusion Center Revenue Market Share by Type (2021-2026) Table 30. Global Ambulatory Infusion Center Revenue Market Share by Type (2027-2032) Table 31. Global Ambulatory Infusion Center Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Ambulatory Infusion Center Revenue Market Share by Application (2021-2026) Table 35. Global Ambulatory Infusion Center Revenue Market Share by Application (2027-2032) Table 36. Option Care Health Company Information Table 37. Option Care Health Business Overview Table 38. Option Care Health Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Option Care Health Ambulatory Infusion Center Product Portfolio Table 40. Option Care Health Recent Development Table 41. Coram CVS Company Information Table 42. Coram CVS Business Overview Table 43. Coram CVS Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Coram CVS Ambulatory Infusion Center Product Portfolio Table 45. Coram CVS Recent Development Table 46. UnitedHealth Group Company Information Table 47. UnitedHealth Group Business Overview Table 48. UnitedHealth Group Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. UnitedHealth Group Ambulatory Infusion Center Product Portfolio Table 50. UnitedHealth Group Recent Development Table 51. HCA Healthcare Company Information Table 52. HCA Healthcare Business Overview Table 53. HCA Healthcare Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. HCA Healthcare Ambulatory Infusion Center Product Portfolio Table 55. HCA Healthcare Recent Development Table 56. McLaren Company Information Table 57. McLaren Business Overview Table 58. McLaren Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. McLaren Ambulatory Infusion Center Product Portfolio Table 60. McLaren Recent Development Table 61. UK HealthCare Company Information Table 62. UK HealthCare Business Overview Table 63. UK HealthCare Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. UK HealthCare Ambulatory Infusion Center Product Portfolio Table 65. UK HealthCare Recent Development Table 66. CHI Health Company Information Table 67. CHI Health Business Overview Table 68. CHI Health Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. CHI Health Ambulatory Infusion Center Product Portfolio Table 70. CHI Health Recent Development Table 71. Accredo Health Company Information Table 72. Accredo Health Business Overview Table 73. Accredo Health Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Accredo Health Ambulatory Infusion Center Product Portfolio Table 75. Accredo Health Recent Development Table 76. PharMerica Company Information Table 77. PharMerica Business Overview Table 78. PharMerica Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. PharMerica Ambulatory Infusion Center Product Portfolio Table 80. PharMerica Recent Development Table 81. Cleveland Clinic Company Information Table 82. Cleveland Clinic Business Overview Table 83. Cleveland Clinic Ambulatory Infusion Center Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Cleveland Clinic Ambulatory Infusion Center Product Portfolio Table 85. Cleveland Clinic Recent Development Table 86. North America Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Ambulatory Infusion Center Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Ambulatory Infusion Center Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Ambulatory Infusion Center Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Ambulatory Infusion Center Revenue by Country (US$ Million) & (2027-2032) Table 100. China Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 101. China Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 102. China Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 103. China Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Ambulatory Infusion Center Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Ambulatory Infusion Center Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Ambulatory Infusion Center Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Ambulatory Infusion Center Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Ambulatory Infusion Center Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Ambulatory Infusion Center Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Ambulatory Infusion Center Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Ambulatory Infusion Center Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Ambulatory Infusion Center Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Ambulatory Infusion Center Image Figure 2. Global Ambulatory Infusion Center Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Infusion Center Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospital Image Figure 5. Clinic Image Figure 6. Home Health Agencies Image Figure 7. Global Ambulatory Infusion Center Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ambulatory Infusion Center Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Image Figure 10. Chronic Disease Image Figure 11. Others Image Figure 12. Global Ambulatory Infusion Center Market Size (US$ Million) & (2021-2032) Figure 13. Global Ambulatory Infusion Center Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ambulatory Infusion Center Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Ambulatory Infusion Center Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Ambulatory Infusion Center Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Ambulatory Infusion Center Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Ambulatory Infusion Center Revenue Market Share by Type (2021-2032) Figure 20. Global Ambulatory Infusion Center Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ambulatory Infusion Center Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Ambulatory Infusion Center Revenue Market Share by Application (2021-2032) Figure 23. North America Ambulatory Infusion Center Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Ambulatory Infusion Center Revenue Share by Type (2021-2032) Figure 25. North America Ambulatory Infusion Center Revenue Share by Application (2021-2032) Figure 26. North America Ambulatory Infusion Center Revenue Share by Country (2021-2032) Figure 27. United States Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Ambulatory Infusion Center Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Ambulatory Infusion Center Revenue Share by Type (2021-2032) Figure 32. Europe Ambulatory Infusion Center Revenue Share by Application (2021-2032) Figure 33. Europe Ambulatory Infusion Center Revenue Share by Country (2021-2032) Figure 34. Germany Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Ambulatory Infusion Center Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Ambulatory Infusion Center Revenue Share by Type (2021-2032) Figure 44. China Ambulatory Infusion Center Revenue Share by Application (2021-2032) Figure 45. Asia Ambulatory Infusion Center Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Ambulatory Infusion Center Revenue Share by Type (2021-2032) Figure 47. Asia Ambulatory Infusion Center Revenue Share by Application (2021-2032) Figure 48. Asia Ambulatory Infusion Center Revenue Share by Region (2021-2032) Figure 49. Japan Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Ambulatory Infusion Center Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Ambulatory Infusion Center Revenue Share by Type (2021-2032) Figure 57. SAMEA Ambulatory Infusion Center Revenue Share by Application (2021-2032) Figure 58. SAMEA Ambulatory Infusion Center Revenue Share by Country (2021-2032) Figure 59. Brazil Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Ambulatory Infusion Center Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Clinic
  • Home Health Agencies
Applications
  • Cancer
  • Chronic Disease
  • Others
Companies covered
  • Option Care Health
  • Coram CVS
  • UnitedHealth Group
  • HCA Healthcare
  • McLaren
  • UK HealthCare
  • CHI Health
  • Accredo Health
  • PharMerica
  • Cleveland Clinic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ambulatory Infusion Center Market by Type
  3. 1.2.1 Global Ambulatory Infusion Center Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hospital
  5. 1.2.3 Clinic
  6. 1.2.4 Home Health Agencies
  7. 1.3 Ambulatory Infusion Center Market by Application
  8. 1.3.1 Global Ambulatory Infusion Center Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Chronic Disease
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ambulatory Infusion Center Market Dynamics
  1. 2.1 Ambulatory Infusion Center Industry Trends
  2. 2.2 Ambulatory Infusion Center Industry Drivers
  3. 2.3 Ambulatory Infusion Center Industry Opportunities and Challenges
  4. 2.4 Ambulatory Infusion Center Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ambulatory Infusion Center Market Perspective (2021-2032)
  2. 3.2 Global Ambulatory Infusion Center Growth Trends by Region
  3. 3.2.1 Global Ambulatory Infusion Center Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ambulatory Infusion Center Market Size by Region (2021-2026)
  5. 3.2.3 Global Ambulatory Infusion Center Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ambulatory Infusion Center Revenue by Players
  2. 4.1.1 Global Ambulatory Infusion Center Revenue by Players (2021-2026)
  3. 4.1.2 Global Ambulatory Infusion Center Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ambulatory Infusion Center Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ambulatory Infusion Center Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ambulatory Infusion Center Key Players Headquarters & Area Served
  7. 4.4 Global Ambulatory Infusion Center Players, Product Type & Application
  8. 4.5 Global Ambulatory Infusion Center Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ambulatory Infusion Center Market CR5 and HHI
  11. 4.6.3 2025 Ambulatory Infusion Center Tier 1, Tier 2, and Tier 3
5 Ambulatory Infusion Center Market Size by Type
  1. 5.1 Global Ambulatory Infusion Center Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 5.3 Global Ambulatory Infusion Center Revenue Market Share by Type (2021-2032)
6 Ambulatory Infusion Center Market Size by Application
  1. 6.1 Global Ambulatory Infusion Center Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ambulatory Infusion Center Revenue by Application (2021-2032)
  3. 6.3 Global Ambulatory Infusion Center Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Option Care Health
  2. 7.1.1 Option Care Health Company Information
  3. 7.1.2 Option Care Health Business Overview
  4. 7.1.3 Option Care Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Option Care Health Ambulatory Infusion Center Product Portfolio
  6. 7.1.5 Option Care Health Recent Developments
  7. 7.2 Coram CVS
  8. 7.2.1 Coram CVS Company Information
  9. 7.2.2 Coram CVS Business Overview
  10. 7.2.3 Coram CVS Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Coram CVS Ambulatory Infusion Center Product Portfolio
  12. 7.2.5 Coram CVS Recent Developments
  13. 7.3 UnitedHealth Group
  14. 7.3.1 UnitedHealth Group Company Information
  15. 7.3.2 UnitedHealth Group Business Overview
  16. 7.3.3 UnitedHealth Group Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  17. 7.3.4 UnitedHealth Group Ambulatory Infusion Center Product Portfolio
  18. 7.3.5 UnitedHealth Group Recent Developments
  19. 7.4 HCA Healthcare
  20. 7.4.1 HCA Healthcare Company Information
  21. 7.4.2 HCA Healthcare Business Overview
  22. 7.4.3 HCA Healthcare Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  23. 7.4.4 HCA Healthcare Ambulatory Infusion Center Product Portfolio
  24. 7.4.5 HCA Healthcare Recent Developments
  25. 7.5 McLaren
  26. 7.5.1 McLaren Company Information
  27. 7.5.2 McLaren Business Overview
  28. 7.5.3 McLaren Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  29. 7.5.4 McLaren Ambulatory Infusion Center Product Portfolio
  30. 7.5.5 McLaren Recent Developments
  31. 7.6 UK HealthCare
  32. 7.6.1 UK HealthCare Company Information
  33. 7.6.2 UK HealthCare Business Overview
  34. 7.6.3 UK HealthCare Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  35. 7.6.4 UK HealthCare Ambulatory Infusion Center Product Portfolio
  36. 7.6.5 UK HealthCare Recent Developments
  37. 7.7 CHI Health
  38. 7.7.1 CHI Health Company Information
  39. 7.7.2 CHI Health Business Overview
  40. 7.7.3 CHI Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CHI Health Ambulatory Infusion Center Product Portfolio
  42. 7.7.5 CHI Health Recent Developments
  43. 7.8 Accredo Health
  44. 7.8.1 Accredo Health Company Information
  45. 7.8.2 Accredo Health Business Overview
  46. 7.8.3 Accredo Health Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Accredo Health Ambulatory Infusion Center Product Portfolio
  48. 7.8.5 Accredo Health Recent Developments
  49. 7.9 PharMerica
  50. 7.9.1 PharMerica Company Information
  51. 7.9.2 PharMerica Business Overview
  52. 7.9.3 PharMerica Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  53. 7.9.4 PharMerica Ambulatory Infusion Center Product Portfolio
  54. 7.9.5 PharMerica Recent Developments
  55. 7.10 Cleveland Clinic
  56. 7.10.1 Cleveland Clinic Company Information
  57. 7.10.2 Cleveland Clinic Business Overview
  58. 7.10.3 Cleveland Clinic Ambulatory Infusion Center Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cleveland Clinic Ambulatory Infusion Center Product Portfolio
  60. 7.10.5 Cleveland Clinic Recent Developments
8 North America
  1. 8.1 North America Ambulatory Infusion Center Revenue (2021-2032)
  2. 8.2 North America Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 8.2.1 North America Ambulatory Infusion Center Revenue by Type (2021-2026)
  4. 8.2.2 North America Ambulatory Infusion Center Revenue by Type (2027-2032)
  5. 8.3 North America Ambulatory Infusion Center Revenue Share by Type (2021-2032)
  6. 8.4 North America Ambulatory Infusion Center Revenue by Application (2021-2032)
  7. 8.4.1 North America Ambulatory Infusion Center Revenue by Application (2021-2026)
  8. 8.4.2 North America Ambulatory Infusion Center Revenue by Application (2027-2032)
  9. 8.5 North America Ambulatory Infusion Center Revenue Share by Application (2021-2032)
  10. 8.6 North America Ambulatory Infusion Center Revenue by Country
  11. 8.6.1 North America Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ambulatory Infusion Center Revenue by Country (2021-2026)
  13. 8.6.3 North America Ambulatory Infusion Center Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ambulatory Infusion Center Revenue (2021-2032)
  2. 9.2 Europe Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ambulatory Infusion Center Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ambulatory Infusion Center Revenue by Type (2027-2032)
  5. 9.3 Europe Ambulatory Infusion Center Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ambulatory Infusion Center Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ambulatory Infusion Center Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ambulatory Infusion Center Revenue by Application (2027-2032)
  9. 9.5 Europe Ambulatory Infusion Center Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ambulatory Infusion Center Revenue by Country
  11. 9.6.1 Europe Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ambulatory Infusion Center Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ambulatory Infusion Center Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ambulatory Infusion Center Revenue (2021-2032)
  2. 10.2 China Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 10.2.1 China Ambulatory Infusion Center Revenue by Type (2021-2026)
  4. 10.2.2 China Ambulatory Infusion Center Revenue by Type (2027-2032)
  5. 10.3 China Ambulatory Infusion Center Revenue Share by Type (2021-2032)
  6. 10.4 China Ambulatory Infusion Center Revenue by Application (2021-2032)
  7. 10.4.1 China Ambulatory Infusion Center Revenue by Application (2021-2026)
  8. 10.4.2 China Ambulatory Infusion Center Revenue by Application (2027-2032)
  9. 10.5 China Ambulatory Infusion Center Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ambulatory Infusion Center Revenue (2021-2032)
  2. 11.2 Asia Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ambulatory Infusion Center Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ambulatory Infusion Center Revenue by Type (2027-2032)
  5. 11.3 Asia Ambulatory Infusion Center Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ambulatory Infusion Center Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ambulatory Infusion Center Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ambulatory Infusion Center Revenue by Application (2027-2032)
  9. 11.5 Asia Ambulatory Infusion Center Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ambulatory Infusion Center Revenue by Country
  11. 11.6.1 Asia Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ambulatory Infusion Center Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ambulatory Infusion Center Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ambulatory Infusion Center Revenue (2021-2032)
  2. 12.2 SAMEA Ambulatory Infusion Center Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ambulatory Infusion Center Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ambulatory Infusion Center Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ambulatory Infusion Center Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ambulatory Infusion Center Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ambulatory Infusion Center Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ambulatory Infusion Center Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ambulatory Infusion Center Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ambulatory Infusion Center Revenue by Country
  11. 12.6.1 SAMEA Ambulatory Infusion Center Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ambulatory Infusion Center Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ambulatory Infusion Center Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst